Skip to content

Julian Baker portfolio · Q2 2026

Baker Bros. Advisors LP · CIK 0001263508 ·13F filings on SEC EDGAR

In Q2 2026, Baker Bros. Advisors LP reported 84 positions worth $20B. Its largest holding was INCY at 17.5% of the portfolio, and the top 10 made up 73%. Its largest new position was FTH ($32.2M), and it sold out of ABVX.

Portfolio value
$20B
Positions
84
Top 10 share
72.8%
Changes vs Mar 31, 2026
  • NEW 8
  • ADD 16
  • REDUCE 7
  • EXIT 8

Portfolio map

NEWADDHOLDREDUCE

Each box is a position sized by its value. Color shows the change in shares from the previous quarter. The smallest 44 positions are grouped as one box.

Portfolio history

Q4 2025 to Q2 2026, 3 quarters

Weight of the largest holdings

The 7 holdings with the highest weight in any quarter shown, stacked with all others to 100%.

INCYONCRVMDMDGLINSMACADCELCOther

Holding timeline

Shade shows the weight in each quarter. A blank cell means the holding was not reported that quarter.

< 1%1–3%3–6%6–10%10–20%20–35%≥ 35%

Holdings

Click a holding to see its price chart with the quarters the investor bought or sold.

NameWeightAvg. cost (est.)Latest priceGain/lossValue
15102KAA8
Celcuity Inc.
PRN
0.35%———$69.2M

Average cost is an estimate, not the investor's actual purchase price: every quarter the share count rose, the added shares are counted at that quarter-end's 13F price, and sales keep the average. Latest price is the most recent 13F quarter-end price (Sep 30, 2026), and value is shares × latest price. * Held since before Mar 31, 2016, when our collected history starts, so the average starts from that quarter's price.

Changes in shares

Change in shares held vs Mar 31, 2026, for the 20 largest positions that changed. Bars are capped at ±100%; the label shows the actual change.

NEWADDREDUCEEXIT

Sold out this quarter

Held on Mar 31, 2026 and not reported for Q2 2026.

StockPrior weightPrior sharesPrior valueChange
ABVX
ABIVAX SA-ADR
0.56%875,796$97.5MEXIT
SYRE
SPYRE THERAPEUTICS INC
0.29%1,000,000$50.4MEXIT
CNTA
CENTESSA PHARMACEUTICALS LTD
0.15%670,751$26.6MEXIT
IMCR
IMMUNOCORE HOLDINGS PLC-ADR
0.13%734,397$22.1MEXIT
CTNM
CONTINEUM THERAPEUTICS INC-A
0.11%1,420,838$18.6MEXIT
ARGX
ARGENX SE - ADR
0.11%25,174$18.4MEXIT
CMPS
COMPASS PATHWAYS PLC
0.07%2,344,720$13MEXIT
PHVS
PHARVARIS NV
0.06%375,000$10.6MEXIT

SEC filings for Q2 2026